14.95 USD
↘ 0.18 (1.19%)AT CLOSE (11:59 AM EDT)
Relay Therapeutics, Inc. Common Stock
RLAYNASDAQ • USD
14.80
↘ 0.15 (1.00%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
14.80
↘ 0.15 (1.00%)
Market: CLOSED
Open?$14.86
High?$15.40
Low?$14.64
Prev. Close?$15.13
Volume?4.1M
Avg. Volume?3.1M
VWAP?$14.97
Rel. Volume?1.33x
Bid / Ask
Bid?$14.60 × 400
Ask?$15.00 × 300
Spread?$0.40
Midpoint?$14.80
Valuation & Ratios
Market Cap?2.7B
Shares Out?178.7M
Float?116.7M
Float %?65.3%
P/E Ratio?N/A
P/B Ratio?4.71
EPS?-$1.55
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?22.61Strong
Quick Ratio?22.61Strong
Cash Ratio?3.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?4.71FAIR▾
P/S?174.00HIGH▾
P/FCF?N/A▾
EV/EBITDA?-8.7CHEAP▾
EV/Sales?168.53HIGH▾
Returns & Efficiency
ROE?-48.8%WEAK▾
ROA?-44.5%WEAK▾
Cash Flow & Enterprise
FCF?$-235865000
Enterprise Value?$2.6B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
Employees
192
Market Cap
2.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-07-16
Address
60 HAMPSHIRE STREET
CAMBRIDGE, MA 02139
Phone: 617-370-8837
CAMBRIDGE, MA 02139
Phone: 617-370-8837